{"id":"NCT00048061","sponsor":"Hoffmann-La Roche","briefTitle":"MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis","officialTitle":"Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-04","primaryCompletion":"2004-12","completion":"2004-12","firstPosted":"2002-10-25","resultsPosted":"2016-05-30","lastUpdate":"2018-03-29"},"enrollment":1609,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Post Menopausal Osteoporosis"],"interventions":[{"type":"DRUG","name":"Ibandronate [Bonviva/Boniva]","otherNames":[]},{"type":"DRUG","name":"Ibandronate [Bonviva/Boniva]","otherNames":[]},{"type":"DRUG","name":"Ibandronate [Bonviva/Boniva]","otherNames":[]},{"type":"DRUG","name":"Ibandronate [Bonviva/Boniva]","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Calcium","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Vitamin D","otherNames":[]}],"arms":[{"label":"Ibandronate 2.5 mg","type":"ACTIVE_COMPARATOR"},{"label":"Ibandronate 50/50 mg","type":"EXPERIMENTAL"},{"label":"Ibandronate 100 mg","type":"EXPERIMENTAL"},{"label":"Ibandronate 150 mg","type":"EXPERIMENTAL"}],"summary":"This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.","primaryOutcome":{"measure":"Relative Change From Baseline at One Year (12 Months) in Mean Lumbar Spine (L2 - L4) Bone Mineral Density","timeFrame":"From Baseline (Month 0) to Month 12","effectByArm":[{"arm":"Ibandronate 2.5 mg","deltaMin":3.7427,"sd":4.0149},{"arm":"Ibandronate 50/50 mg","deltaMin":4.3395,"sd":3.9557},{"arm":"Ibandronate 100 mg","deltaMin":4.0328,"sd":3.6815},{"arm":"Ibandronate 150 mg","deltaMin":4.7611,"sd":3.8931}],"pValues":[{"comp":"OG000 vs OG001","p":"0.045"},{"comp":"OG000 vs OG002","p":"0.338"},{"comp":"OG000 vs OG003","p":"0.001"}]},"eligibility":{"minAge":"55 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":68,"countries":["United States","Australia","Belgium","Brazil","Canada","Czechia","Denmark","France","Germany","Hungary","Italy","Mexico","Norway","Poland","Romania","South Africa","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":395},"commonTop":["Hypertension","Arthralgia","Back pain","Dyspepsia","Nasopharyngitis"]}}